Gerresheimer AG Delays Financial Statements, Plans Sale of Centor Inc.

Gerresheimer AG has announced a delay in the publication of its 2025 annual and consolidated financial statements, originally set for February 26, 2026. This decision follows investigations into revenue recognition and accounting practices for the 2024 and 2025 financial years. The company is carrying out these investigations with a second auditing firm and an independent law firm due to findings that suggest violations of guidelines and accounting standards occurred.

Gerresheimer has initiated the sale of its subsidiary, Centor Inc., as part of a capital optimization strategy. The company plans to complete this sale by the end of 2026. Despite the internal corrections, Gerresheimer predicts a decrease in revenues and adjusted EBITDA for 2025, with a projected revenue decline of 4% to 2% and EBITDA margin of 16.5% to 17.5%. Impairment tests conducted indicate expected non-cash impairments of EUR 220 to 240 million.